GlassScriptPhysician profile
Jay M Mashouf
NPI 1346294584
$13,626.60
in general payments reported to CMS, 2019-2025
17 companies · $971 in 2025
The $971 reported for 2025 was more than what 84% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $31.95 · 2021: $547 · 2022: $1,848 · 2023: $2,474 · 2024: $6,211 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,830 · Food and Beverage: $3,401 · Travel and Lodging: $975 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,830.00 |
| Food and Beverage | $3,400.86 |
| Travel and Lodging | $975.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,337.44 | 2019-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Tarsus Pharmaceuticals, INC. | $4,009.80 | 2024-2025 | Xdemvy |
| Alcon Research LLC | $1,680.00 | 2024 | Dailies Total1, Total30 |
| Bausch & Lomb Americas INC. | $1,145.50 | 2022-2025 | Infuse |
| Coopervision INC. | $437.88 | 2019-2023 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $382.28 | 2019-2021 | |
| Biotissue Holdings INC. | $346.61 | 2019-2024 | |
| Ocular Therapeutix, INC. | $256.96 | 2021-2025 | Dextenza |
| Sight Sciences, INC. | $237.91 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $221.79 | 2025 | Acuvue |
| Harrow Eye, LLC | $126.66 | 2024 | Vevye |
| Apellis Pharmaceuticals, INC. | $121.87 | 2023 | |
| Allergan, INC. | $116.22 | 2022 | |
| Glaukos Corporation | $110.23 | 2023-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Idosetr |
| Abbvie INC. | $46.21 | 2022-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $30.24 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Mashouf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.